Page last updated: 2024-08-24

iobitridol and Hyperlipoproteinemia Type II

iobitridol has been researched along with Hyperlipoproteinemia Type II in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alomar Serrallach, X; Barros Membrilla, A; Cardona Olle, M; Carreras Costa, F; Franco Peral, M; Hidalgo Perez, JA; Leta Petracca, R; Pons-Lladó, G; Pujadas Olano, S; Viladés Medel, D1

Other Studies

1 other study(ies) available for iobitridol and Hyperlipoproteinemia Type II

ArticleYear
Coronary computed tomographic angiographic findings in asymptomatic patients with heterozygous familial hypercholesterolemia and null allele low-density lipoprotein receptor mutations.
    The American journal of cardiology, 2013, Apr-01, Volume: 111, Issue:7

    Topics: Age Factors; Alleles; Case-Control Studies; Chi-Square Distribution; Comorbidity; Contrast Media; Coronary Angiography; Coronary Artery Disease; Female; Humans; Hyperlipoproteinemia Type II; Iohexol; Lipids; Logistic Models; Male; Middle Aged; Mutation; Phenotype; Prevalence; Receptors, LDL; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Tomography, X-Ray Computed

2013